Transparent Artificial Medical Intelligence 



The current rise of Artificial Intelligence (AI) has brought exciting advances in a wide range of applications, greatly boosted by the availability of large and diverse datasets, improved algorithms, and new levels of computing power. But despite the spectacular successes, there are still huge challenges. The internal logic and inner workings of many state-of-the-art AI models are hidden to the user, which prevents humans from being able to verify, interpret, and understand the reasoning of the system and how particular decisions are made. These crucial needs and concerns are currently one of the main obstacles for wider AI usage, being responsible for the emergence in recent years of the Explainable Artificial Intelligence (XAI), a field of study that aims to make a shift towards a more transparent and interpretable AI. 



TAMI envisions to build high-performing XAI systems for application in medicine, whose workings and outputs can be understood and cross-examined by users through  human-friendly explanations of the automated results. Our research will be focused on the following topics: 


> Generate self-explanatory AI-based decisions that minimize bias, act ethically in their context and enhance trust of the end-users 

> Customizable multimodal and privacy-preserving explanations, that adapt to who will consume them 

> Quantitative methods to objectively evaluate and compare the suitability of different types of explanations for specific use cases 

> Foster new strategies for presenting human understandable explanations 


Furthermore, the project aims to create a new XAI-based platform for healthcare actors in four main imagiological domains: Cervical Cytology, Cervical Colposcopy, Glaucoma and Chest X-Rays. The TAMI platform will be available for commercial, scientific and academic use, and will provide "consumers" access to self-explanatory AI decisions for target screening and diagnosis procedures, as well as access to filtered and anonymized datasets for research purposes. 



Led by the company First Solutions, TAMI is a three-year project (2020-2023) being developed in partnership with Fraunhofer AICOS, INESC TEC, Administração Regional de Saúde do Norte and Carnegie Mellon University.


Clinical Partners:

Hospital Prof. Dr. Fernando Fonseca; Instituto Português de Oncologia do Porto; Centro Hospitalar do Porto. 



TAMI Brochure

Consult the project's Spec Sheet here:



Co-funded by:

For any additional information, please contact us using the inquiries form.